Baylor University Medical Center at Dallas Performs it’s First Islet Cell Transplant

This procedure offers hope for reducing the number of people who need kidney transplants by offering an effective treatment for juvenile onset diabetes.

Baylor received approval from the Food and Drug Administration to begin a research study of islet cell transplantation in July 2004. Fifteen patients, both men and women, between the ages of 18 and 65 will be enrolled in the study. Nationwide, more than one million people have Type 1 (juvenile onset) diabetes, and, each year, nearly 130,000 people receive kidney transplants as a result of the disease.